1. Hao, Xiaopei, Zheng, Zhiying, Liu, Hanyuan, Tang, Weiwei, Wang, Xuehao. 2022. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. In Redox biology, 56, 102463. doi:10.1016/j.redox.2022.102463. https://pubmed.ncbi.nlm.nih.gov/36108528/
2. Yang, Shimin, Du, Jingxiao, Wang, Wei, Zhou, Dongmei, Xi, Xiaowei. 2024. APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer. In BMC cancer, 24, 364. doi:10.1186/s12885-024-12105-z. https://pubmed.ncbi.nlm.nih.gov/38515073/
3. Ren, Liwen, Yi, Jie, Yang, Yihui, Wang, Xifu, Wang, Jinhua. 2022. Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis. In Pharmacological research, 183, 106376. doi:10.1016/j.phrs.2022.106376. https://pubmed.ncbi.nlm.nih.gov/35914680/
4. Yu, Kuipeng, Ding, Lin, An, Xin, Bai, Fang, Yang, Xiangdong. 2023. APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN. In Frontiers in pharmacology, 14, 1181435. doi:10.3389/fphar.2023.1181435. https://pubmed.ncbi.nlm.nih.gov/37305534/
5. Zheng, Xiang-Jin, Chen, Wen-Lin, Yi, Jie, Wang, Yu, Wang, Jin-Hua. 2022. Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis. In Acta pharmacologica Sinica, 43, 2977-2992. doi:10.1038/s41401-022-00917-3. https://pubmed.ncbi.nlm.nih.gov/35581292/
6. Jia, Yongxu, Zhang, Baifeng, Zhang, Chunyang, Guan, Xinyuan, Qin, Yanru. 2023. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2204565. doi:10.1002/advs.202204565. https://pubmed.ncbi.nlm.nih.gov/36709495/
7. Mei, Langhua, Long, Jian, Wu, Shue, Mei, Di, Qiu, Huaping. 2024. APOC1 reduced anti-PD-1 immunotherapy of nonsmall cell lung cancer via the transformation of M2 into M1 macrophages by ferroptosis by NRF2/HO-1. In Anti-cancer drugs, 35, 333-343. doi:10.1097/CAD.0000000000001573. https://pubmed.ncbi.nlm.nih.gov/38241194/